Advocacy

Home / Advocacy

Advocacy

 

The AMP advocacy program endeavors to inform and influence public policy affecting molecular pathology.  AMP represents its membership to the federal agencies and members of Congress regarding professional and reimbursement issues - reaching out to fellow professional associations, industry and other association partners to accomplish common goals. 

Position statements, comments, and letters are usually generated by our Professional Relations and Economic Affairs Committees, though our Clinical Practice and Training & Education Committees do advocate in their areas. We invite you to explore AMP's Position Statements and Letters. For more information, please contact Mary Williams.

View all AMP Position Statements and Letters

 

Recent Advocacy News, Position Statements and Letters

AMP Comments to AHRQ on Genetic Testing

April 2013

View the comments

AMP Reaffirms Comments to House on Health Information Technology Reform Act

April 2013

View the comments

AMP Comments to FDA on Drug Labeling

March 2013

View the letter

AMP Comments to FDA on Alternative Approval Pathways

March 2013

View the letter

AMP Comments to USTPO on Genetic Diagnostic Testing

January 2013

View the letter